{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:53:24Z","timestamp":1787162004632,"version":"build-2736575974"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>Many neurodegenerative diseases, such as Alzheimer\u2019s disease (AD) and frontotemporal dementia with Parkinsonism linked to chromosome 17, are characterized by tau pathology. Numerous motor proteins, many of which are involved in synaptic transmission, mediate transport in neurons. Dysfunction in motor protein-mediated neuronal transport mechanisms occurs in several neurodegenerative disorders but remains understudied in AD. Kinesins are the most important molecular motor proteins required for microtubule-dependent transport in neurons, and kinesin-1 is crucial for neuronal transport among all kinesins. Although kinesin-1 is required for normal neuronal functions, the dysfunction of these motor domains leading to neurodegenerative diseases is not fully understood. Here, we reported that the kinesin-I heavy chain (KIF5B), a key molecular motor protein, is involved in tau homeostasis in AD cells and animal models. We found that the levels of KIF5B in P301S tau mice are high. We also found that the knockdown and knockout (KO) of KIFf5B significantly decreased the tau stability, and overexpression of KIF5B in KIF5B-KO cells significantly increased the expression of phosphorylated and total tau levels. This suggested that KIF5B might prevent tau accumulation. By conducting experiments on P301S tau mice, we showed that partially reducing KIF5B levels can reduce hyperphosphorylation of the human tau protein, formation of insoluble aggregates, and memory impairment. Collectively, our results suggested that decreasing KIF5B levels is sufficient to prevent and\/or slow down abnormal tau behavior of AD and other tauopathies.<\/jats:p>","DOI":"10.3389\/fmolb.2022.1050768","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T03:53:15Z","timestamp":1666669995000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Reduction of kinesin I heavy chain decreases tau hyperphosphorylation, aggregation, and memory impairment in Alzheimer\u2019s disease and tauopathy models"],"prefix":"10.3389","volume":"9","author":[{"given":"Karthikeyan","family":"Selvarasu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Iyaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sravan","family":"Gopalkrishnashetty Sreenivasmurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthilkumar","family":"Krishnamoorthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal Kanti","family":"Bera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Dong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siva Sundara Kumar","family":"Durairajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"9340","DOI":"10.1523\/JNEUROSCI.22-21-09340.2002","article-title":"Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein","volume":"22","author":"Allen","year":"2002","journal-title":"J. Neurosci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/s0197-4580(97)00056-0","article-title":"Frequency of stages of Alzheimer-related lesions in different age categories","volume":"18","author":"Braak","year":"1997","journal-title":"Neurobiol. Aging"},{"key":"B4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e34724","DOI":"10.1371\/journal.pone.0034724","article-title":"Reduced axonal transport and increased excitotoxic retinal ganglion cell degeneration in mice transgenic for human mutant P301S tau","volume":"7","author":"Bull","year":"2012","journal-title":"PLoS One"},{"key":"B6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/brain\/awx347","article-title":"Tau burden and the functional connectome in Alzheimer\u2019s disease and progressive supranuclear palsy","volume":"141","author":"Cope","year":"2018","journal-title":"Brain"},{"key":"B7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neurobiolaging.2016.07.015","article-title":"Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition","volume":"47","author":"Cox","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1096\/fj.08-109181","article-title":"Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin","volume":"22","author":"Cuchillo-Ibanez","year":"2008","journal-title":"FASEB J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.neuro.31.061307.090711","article-title":"Role of axonal transport in neurodegenerative diseases","volume":"31","author":"De Vos","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1126\/science.1152993","article-title":"Differential regulation of dynein and kinesin motor proteins by tau","volume":"319","author":"Dixit","year":"2008","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1016\/j.neurobiolaging.2012.02.016","article-title":"Berberine ameliorates \u03b2-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer\u2019s disease transgenic mouse model","volume":"33","author":"Durairajan","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"B12","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1083\/jcb.143.3.777","article-title":"Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: Implications for Alzheimer\u2019s disease","volume":"143","author":"Ebneth","year":"1998","journal-title":"J. Cell. Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1093\/hmg\/ddq363","article-title":"Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies","volume":"19","author":"Falzone","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/brain\/awz026","article-title":"Functional connectivity associated with tau levels in ageing, Alzheimer\u2019s, and small vessel disease","volume":"142","author":"Franzmeier","year":"2019","journal-title":"Brain"},{"key":"B15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.tcb.2014.07.005","article-title":"Connecting the dots between tau dysfunction and neurodegeneration","volume":"25","author":"Frost","year":"2015","journal-title":"Trends Cell. Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/s0896-6273(03)00630-5","article-title":"Do disorders of movement cause movement disorders and dementia?","volume":"40","author":"Goldstein","year":"2003","journal-title":"Neuron"},{"key":"B17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-pathmechdis-012418-012936","article-title":"Molecular pathogenesis of the tauopathies","volume":"14","author":"G\u00f6tz","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/j.1471-4159.2006.03955.x","article-title":"Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer\u2019s disease?","volume":"98","author":"G\u00f6tz","year":"2006","journal-title":"J. Neurochem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3233\/JAD-170094","article-title":"Overexpression of kinesin superfamily motor proteins in Alzheimer\u2019s disease","volume":"60","author":"Hares","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bbapap.2005.02.013","article-title":"Understanding molecular mechanisms of proteolysis in Alzheimer\u2019s disease: Progress toward therapeutic interventions","volume":"1751","author":"Higuchi","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"B22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1385\/NMM:2:2:131","article-title":"Tau and axonopathy in neurodegenerative disorders","volume":"2","author":"Higuchi","year":"2002","journal-title":"Neuromolecular Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrn1624","article-title":"Molecular motors and mechanisms of directional transport in neurons","volume":"6","author":"Hirokawa","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.neuron.2010.09.039","article-title":"Molecular motors in neurons: Transport mechanisms and roles in brain function, development, and disease","volume":"68","author":"Hirokawa","year":"2010","journal-title":"Neuron"},{"key":"B25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/17460441.2018.1445084","article-title":"Recent developments with tau-based drug discovery","volume":"13","author":"Iqbal","year":"2018","journal-title":"Expert Opin. Drug Discov."},{"key":"B26","doi-asserted-by":"publisher","first-page":"15997","DOI":"10.1073\/pnas.0808084105","article-title":"Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia","volume":"105","author":"Ittner","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B27","doi-asserted-by":"publisher","first-page":"153648","DOI":"10.1016\/j.phymed.2021.153648","article-title":"Qingyangshen mitigates amyloid-\u03b2 and Tau aggregate defects involving PPAR\u03b1-TFEB activation in transgenic mice of Alzheimer\u2019s disease","volume":"91","author":"Iyaswamy","year":"2021","journal-title":"Phytomedicine."},{"key":"B28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.expneurol.2012.06.003","article-title":"Axonal degeneration in Alzheimer\u2019s disease: When signaling abnormalities meet the axonal transport system","volume":"246","author":"Kanaan","year":"2013","journal-title":"Exp. Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e35678","DOI":"10.1371\/journal.pone.0035678","article-title":"Tau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer\u2019s and Pick\u2019s disease","volume":"7","author":"Ke","year":"2012","journal-title":"PLoS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.1523\/j.neurosci.16-18-05583.1996","article-title":"Tau binds to the distal axon early in development of polarity in a microtubule- and microfilament-dependent manner","volume":"16","author":"Kempf","year":"1996","journal-title":"J. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3389\/fnins.2017.00572","article-title":"Axonal degeneration in tauopathies: Disease relevance and underlying mechanisms","volume":"11","author":"Kneynsberg","year":"2017","journal-title":"Front. Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s40478-014-0144-4","article-title":"Abundant kif21b is associated with accelerated progression in neurodegenerative diseases","volume":"2","author":"Kreft","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/jnr.21850","article-title":"The amino terminus of tau inhibits kinesin-dependent axonal transport: Implications for filament toxicity","volume":"87","author":"LaPointe","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"7817","DOI":"10.1523\/JNEUROSCI.6412-10.2011","article-title":"Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer\u2019s-like axonal dystrophy","volume":"31","author":"Lee","year":"2011","journal-title":"J. Neurosci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.isci.2019.02.009","article-title":"Kinesin-1 regulates extrasynaptic targeting of NMDARs and neuronal vulnerability toward excitotoxicity","volume":"13","author":"Lin","year":"2019","journal-title":"iScience"},{"key":"B36","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1523\/JNEUROSCI.2028-17.2017","article-title":"Entorhinal tau pathology, episodic memory decline, and neurodegeneration in aging","volume":"38","author":"Maass","year":"2018","journal-title":"J. Neurosci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1083\/jcb.201106120","article-title":"Autophagosomes initiate distally and mature during transport toward the cell soma in primary neurons","volume":"196","author":"Maday","year":"2012","journal-title":"J. Cell. Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.neurobiolaging.2003.04.007","article-title":"Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses","volume":"24","author":"Mandelkow","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"B39","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.1523\/JNEUROSCI.16-18-05727.1996","article-title":"A spatial gradient of tau protein phosphorylation in nascent axons","volume":"16","author":"Mandell","year":"1996","journal-title":"J. Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"42873","DOI":"10.1074\/jbc.M111.292987","article-title":"The nucleotide-binding state of microtubules modulates kinesin processivity and the ability of Tau to inhibit kinesin-mediated transport","volume":"286","author":"McVicker","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nn.2346","article-title":"Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin","volume":"12","author":"Morfini","year":"2009","journal-title":"Nat. Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nm.4011","article-title":"Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling","volume":"22","author":"Myeku","year":"2016","journal-title":"Nat. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41421-018-0067-5","article-title":"A new role of anterograde motor Kif5b in facilitating large clathrin-coated vesicle mediated endocytosis via regulating clathrin uncoating","volume":"4","author":"Ni","year":"2018","journal-title":"Cell. Discov."},{"key":"B44","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature08538","article-title":"Multimodal techniques for diagnosis and prognosis of Alzheimer\u2019s disease","volume":"461","author":"Perrin","year":"2009","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","first-page":"15395","DOI":"10.1074\/jbc.273.25.15395","article-title":"Two kinesin light chain genes in mice. Identification and characterization of the encoded proteins","volume":"273","author":"Rahman","year":"1998","journal-title":"J. Biol. Chem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"13738","DOI":"10.1073\/pnas.1715115115","article-title":"A small-molecule activator of kinesin-1 drives remodeling of the microtubule network","volume":"114","author":"Randall","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B47","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/alz.12452","article-title":"Current directions in tau research: Highlights from Tau 2020","volume":"18","author":"Sexton","year":"2022","journal-title":"Alzheimers Dement."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e13069","DOI":"10.1111\/acel.13069","article-title":"A small molecule transcription factor EB activator ameliorates beta-amyloid precursor protein and Tau pathology in Alzheimer's disease models","volume":"19","author":"Song","year":"2020","journal-title":"Aging Cell."},{"key":"B49","doi-asserted-by":"publisher","first-page":"153887","DOI":"10.1016\/j.phymed.2021.153887","article-title":"Protopine promotes the proteasomal degradation of pathological tau in Alzheimer\u2019s disease models via HDAC6 inhibition","volume":"96","author":"Sreenivasmurthy","year":"2022","journal-title":"Phytomedicine."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1083\/jcb.200108057","article-title":"Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress","volume":"156","author":"Stamer","year":"2002","journal-title":"J. Cell. Biol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1126\/science.1105681","article-title":"Axonopathy and transport deficits early in the pathogenesis of Alzheimer\u2019s disease","volume":"307","author":"Stokin","year":"2005","journal-title":"Science"},{"key":"B52","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3233\/JAD-170168","article-title":"Extracellular tau oligomers induce invasion of endogenous tau into the somatodendritic compartment and axonal transport dysfunction","volume":"58","author":"Swanson","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/s0092-8674(00)81459-2","article-title":"Targeted disruption of mouse conventional kinesin heavy chain, kif5B, results in abnormal perinuclear clustering of mitochondria","volume":"93","author":"Tanaka","year":"1998","journal-title":"Cell."},{"key":"B54","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.nbd.2019.03.021","article-title":"Amyloid beta-mediated KIF5A deficiency disrupts anterograde axonal mitochondrial movement","volume":"127","author":"Wang","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/nan.12160","article-title":"Memory deficits correlate with tau and spine pathology in P301S MAPT transgenic mice","volume":"40","author":"Xu","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1080\/15548627.2017.1379633","article-title":"NRBF2 is involved in the autophagic degradation process of APP-CTFs in Alzheimer disease models","volume":"13","author":"Yang","year":"2017","journal-title":"Autophagy"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e53456","DOI":"10.7554\/eLife.53456","article-title":"Specific depletion of the motor protein KIF5B leads to deficits in dendritic transport, synaptic plasticity and memory","volume":"9","author":"Zhao","year":"2020","journal-title":"Elife"}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.1050768\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T03:53:17Z","timestamp":1666669997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.1050768\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":58,"alternative-id":["10.3389\/fmolb.2022.1050768"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2022.1050768","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,25]]},"article-number":"1050768"}}